138 related articles for article (PubMed ID: 36708169)
1. Autophagy and podocytopathy.
Ponticelli C; Moroni G; Reggiani F
Nephrol Dial Transplant; 2023 Aug; 38(9):1931-1939. PubMed ID: 36708169
[TBL] [Abstract][Full Text] [Related]
2. Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies.
Zeng C; Fan Y; Wu J; Shi S; Chen Z; Zhong Y; Zhang C; Zen K; Liu Z
J Pathol; 2014 Oct; 234(2):203-13. PubMed ID: 24870816
[TBL] [Abstract][Full Text] [Related]
3. Podocyte injury and its consequences.
Nagata M
Kidney Int; 2016 Jun; 89(6):1221-30. PubMed ID: 27165817
[TBL] [Abstract][Full Text] [Related]
4. Nephrinuria and podocytopathies.
Kostovska I; Trajkovska KT; Topuzovska S; Cekovska S; Labudovic D; Kostovski O; Spasovski G
Adv Clin Chem; 2022; 108():1-36. PubMed ID: 35659057
[TBL] [Abstract][Full Text] [Related]
5. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
[TBL] [Abstract][Full Text] [Related]
6. Targeting podocyte-associated diseases.
Leeuwis JW; Nguyen TQ; Dendooven A; Kok RJ; Goldschmeding R
Adv Drug Deliv Rev; 2010 Nov; 62(14):1325-36. PubMed ID: 20828590
[TBL] [Abstract][Full Text] [Related]
7. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
[TBL] [Abstract][Full Text] [Related]
8. Podocyte-specific deletion of tubular sclerosis complex 2 promotes focal segmental glomerulosclerosis and progressive renal failure.
Iwata W; Unoki-Kubota H; Kato H; Shimizu A; Matsumoto M; Imasawa T; Igarashi A; Matsumoto K; Noda T; Terauchi Y; Nangaku M; Kasuga M; Kaburagi Y
PLoS One; 2020; 15(3):e0229397. PubMed ID: 32191726
[TBL] [Abstract][Full Text] [Related]
9. A critical role of the podocyte cytoskeleton in the pathogenesis of glomerular proteinuria and autoimmune podocytopathies.
Ye Q; Lan B; Liu H; Persson PB; Lai EY; Mao J
Acta Physiol (Oxf); 2022 Aug; 235(4):e13850. PubMed ID: 35716094
[TBL] [Abstract][Full Text] [Related]
10. Signal regulatory protein α protects podocytes through promoting autophagic activity.
Li L; Liu Y; Li S; Yang R; Zeng C; Rong W; Liang H; Zhang M; Zhu X; Kidder K; Liu Y; Liu Z; Zen K
JCI Insight; 2019 Mar; 5(9):. PubMed ID: 30888336
[TBL] [Abstract][Full Text] [Related]
11. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK
J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559
[TBL] [Abstract][Full Text] [Related]
12. mVps34 deletion in podocytes causes glomerulosclerosis by disrupting intracellular vesicle trafficking.
Chen J; Chen MX; Fogo AB; Harris RC; Chen JK
J Am Soc Nephrol; 2013 Feb; 24(2):198-207. PubMed ID: 23291473
[TBL] [Abstract][Full Text] [Related]
13. Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis.
Lenoir O; Jasiek M; Hénique C; Guyonnet L; Hartleben B; Bork T; Chipont A; Flosseau K; Bensaada I; Schmitt A; Massé JM; Souyri M; Huber TB; Tharaux PL
Autophagy; 2015; 11(7):1130-45. PubMed ID: 26039325
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.
Lee HS
Cell Tissue Res; 2012 Jan; 347(1):129-40. PubMed ID: 21541658
[TBL] [Abstract][Full Text] [Related]
15. COL4A3/COL4A4 mutations link familial hematuria and focal segmental glomerulosclerosis. glomerular epithelium destruction via basement membrane thinning?
Voskarides K; Pierides A; Deltas C
Connect Tissue Res; 2008; 49(3):283-8. PubMed ID: 18661361
[TBL] [Abstract][Full Text] [Related]
16. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
[TBL] [Abstract][Full Text] [Related]
17. Reduced Lon protease 1 expression in podocytes contributes to the pathogenesis of podocytopathy.
Gong W; Song J; Liang J; Ma H; Wu W; Zhang Y; Yang L; Huang S; Jia Z; Zhang A
Kidney Int; 2021 Apr; 99(4):854-869. PubMed ID: 33181155
[TBL] [Abstract][Full Text] [Related]
18. CLEC14A protects against podocyte injury in mice with adriamycin nephropathy.
Su Z; Li Y; Lv H; Cui X; Liu M; Wang Z; Zhang Y; Zhen J; Tang W; Wang X; Yi F
FASEB J; 2021 Jul; 35(7):e21711. PubMed ID: 34107098
[TBL] [Abstract][Full Text] [Related]
19. Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases.
Sever S; Schiffer M
Kidney Int; 2018 Jun; 93(6):1298-1307. PubMed ID: 29678354
[TBL] [Abstract][Full Text] [Related]
20. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
